Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf ...

New AARP Report Finds Medicare Part D Enrollees Who Reach the New $2,000 Out-of-Pocket Spending Cap Will Save Thousands Despite Premium Changes ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Millions of seniors with Medicare prescription drug plans have out of pocket costs capped at $2,000 per year because of a new ...